Pressures mount in sleep market
NEW YORK – HME providers report sleep patient volume is still growing, but not as much as in the past.
Sleep patient volume grew 3.6% in the last 12 months and is expected to grow 6% in the next 12 months, according to respondents to the “HME Sleep and Oxygen Survey” for the second quarter of this year, conducted by Needham & Co., a subsidiary of The Needham Group, an investment banking and asset management firm.
However, sleep patient volume was 6.6% and 7.9%, respectively, in a prior survey.
Providers also report that flow generator prices have declined 3.2%, compared to 2.1% in a prior survey, and mask prices have declined 2.4% vs. 1.4%. Driving lower pricing: the latest Medicare reimbursement cuts, according to Needham.
Other highlights from the report include ratings for ResMed’s flow generators have decreased, while ratings for Philips Respironics’ flow generators have increased. Flow generators from both companies are now both at 5.8 out of 7, according to the survey.
The survey also polled HME providers on home oxygen therapy. They report portable oxygen concentrators are expected to increase from 22.4% of the market to 26.8% of the market over the next 12 months. The highest rated POC, at 5.8 out of 7, was a private label device from Inogen, followed by the SimplyGo from Respironics and the G3 from Inogen.
The survey results are based on 87 respondents.